Together Pharma

Medical Cannabis

Health Tech & Life Sciences
Public on TASE on Jan, 2000<br>

Company Overview

Snapshot

Founded in July 1991, Together Pharma operates with 11–50 employees. The company has raised a total of $3.79M across three funding rounds from Hachshara Insurance Company. In January 2000, Together Pharma became publicly listed on the TASE.

Business overview

Together Pharma specializes in the cultivation and production of medical cannabis, developing quality plants suitable for supervised medical use according to strict IMC-GAP standards. The company's system leverages advanced technologies for control and supervision of cannabis plants. It serves the health tech and life sciences sectors, with a focus on pharmaceuticals and ag tech, and has expanded its operations to include a skincare subsidiary in partnership with Premier Dead Sea Cosmetics Laboratories. Together Pharma, along with its subsidiary Globus Pharma, holds the franchise to grow, produce, and distribute medical cannabis products, offering THC Rich, CBD Rich, and CBD/THC Balanced products to markets including Brazil, China, Canada, Europe, Germany, and Uganda.

Strategic signal

In December 2022, Together Pharma partnered with Cantourage and Cannabis House to increase the availability of medical cannabis in Poland. This collaboration signals the company's continued strategic expansion into European markets, leveraging partnerships to broaden its distribution network and meet growing international demand for medical cannabis products.

Company Intelligence Q&A

When did Together Pharma become publicly listed?
Together Pharma became publicly listed on the TASE in January 2000.
What was a significant partnership for Together Pharma in late 2022?
In December 2022, Together Pharma partnered with Cantourage and Cannabis House to increase the availability of medical cannabis in Poland.
What was a key commercial agreement for Together Pharma in October 2022?
In October 2022, Together Pharma’s subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ subsidiary signed their first commercial agreement for medical cannabis products.
When did Together Pharma begin selling medical cannabis in Germany?
Together Pharma sold its first medical cannabis in Germany in December 2021.
What was a significant acquisition for Together Pharma in June 2019?
In June 2019, Together Pharma acquired Jerusalem-based Cannabliss for $3.9 million, as reported by Calcalistech.

External links